RAC 0.60% $1.69 race oncology ltd

Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing, page-73

  1. 2,847 Posts.
    lightbulb Created with Sketch. 3492
    The dosing schedule (and further data) was included in the original decitabine synergy announcement (March 2022).

    https://www.raceoncology.com/wp-content/uploads/2022/03/Zantrene-Highly-Effective-in-a-Mouse-Model-of-Extramedullary-AML.pdf

    https://hotcopper.com.au/data/attachments/6173/6173155-a70cabc680b50d7750e27c5965190ecc.jpg

 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.69
Change
0.010(0.60%)
Mkt cap ! $287.1M
Open High Low Value Volume
$1.69 $1.70 $1.65 $89.01K 53.2K

Buyers (Bids)

No. Vol. Price($)
1 2342 $1.69
 

Sellers (Offers)

Price($) Vol. No.
$1.70 5 1
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.